StockGuru Blog: Genesis Technology – Focusing on Hepatitis B Treatment
GTEC Stock Guru Profile Lotus Pharmaceuticals, Inc., has advanced in the development of a treatment for Hepatitis B and also increased its number of local outlets to 15 retail stores. China offers a huge pool of subjects for study and a promising market for any resulting treatments. Asia is home to about three-quarters of the world’s liver cancers, caused largely by Hepatitis B infections. The World Health Organization (WHO) recently noted around 500,000 people worldwide die of liver cancer each year. Up to 80% of the cases are related to hepatitis B, said the World Health Organization that warned that…